What are Sarcopenia biomarkers
Sarcopenia biomarkers are blood signals that map the biology of age‑related muscle loss. They show how much muscle you have, how actively it’s being renewed, and whether your body is leaning toward building or breaking down. Some come directly from muscle and reflect quantity (creatinine) and local growth brakes or accelerators (myostatin, follistatin). Others capture whole‑body forces that shape muscle health—anabolic drivers that support repair and synthesis (IGF‑1, testosterone) and inflammatory cues that push tissue toward breakdown (C‑reactive protein, interleukin‑6, TNF‑α). Nutrient‑hormone supports reveal readiness of the muscle system (vitamin D). Pairing signals can sharpen the picture—comparing a muscle‑linked marker with one not tied to muscle (creatinine with cystatin C) helps estimate true muscle mass behind routine numbers. Together, these biomarkers translate invisible shifts in skeletal muscle biology into measurable data, enabling earlier recognition of sarcopenia, more tailored exercise and nutrition strategies, and objective tracking of change over time.
Why is blood testing for Sarcopenia important?
- Check hormone and protein signals linked to sarcopenia, muscle strength, and mass.
- Spot early muscle loss risk via low IGF-1, reflecting weaker growth signals.
- Clarify fatigue, weakness, or low libido by detecting testosterone deficiency, especially in men.
- Guide nutrition and training by using albumin to flag inadequate protein intake or inflammation.
- Distinguish normal aging from treatable low testosterone using age-adjusted ranges and symptoms.
- Inform therapy choices, including resistance training, protein targets, or hormone specialist referral when warranted.
- Protect fertility by identifying low testosterone before considering therapies that suppress sperm.
- Track progress by rechecking levels, best interpreted with strength tests and body composition.
What insights will I get?
Sarcopenia blood testing provides insight into the body’s ability to maintain muscle mass, strength, and function—key elements for overall vitality, mobility, and resilience as we age. Muscle health is deeply connected to energy metabolism, cardiovascular stability, cognitive performance, and immune defense. At Superpower, we assess three core biomarkers for sarcopenia risk: IGF-1, Testosterone, and Albumin.
IGF-1 (Insulin-like Growth Factor 1) is a hormone that signals muscle growth and repair, reflecting the body’s anabolic (building) capacity. Testosterone, present in all genders but at higher levels in males, also drives muscle protein synthesis and supports muscle maintenance. Albumin, a major blood protein, indicates overall nutritional status and the body’s ability to build and repair tissues, including muscle.
Healthy levels of IGF-1 and testosterone support stable muscle mass and function, helping to prevent the gradual loss of muscle (sarcopenia) that can compromise mobility and independence. Albumin acts as a marker of systemic stability; low levels may signal chronic illness, inflammation, or malnutrition, all of which can accelerate muscle loss. Together, these biomarkers provide a window into the body’s capacity to preserve muscle and adapt to physical demands.
Interpretation of these results depends on factors such as age, sex, acute or chronic illness, medication use (like steroids or hormone therapy), and laboratory assay differences. For example, normal ranges shift with age and between sexes, and temporary changes can occur during illness or recovery.
.avif)
.svg)
.svg)
.svg)
.svg)
.avif)
.svg)
.avif)
.avif)
.avif)
.avif)
.avif)
.svg)
